234 related articles for article (PubMed ID: 30936419)
1. Kdm6b regulates context-dependent hematopoietic stem cell self-renewal and leukemogenesis.
Mallaney C; Ostrander EL; Celik H; Kramer AC; Martens A; Kothari A; Koh WK; Haussler E; Iwamori N; Gontarz P; Zhang B; Challen GA
Leukemia; 2019 Oct; 33(10):2506-2521. PubMed ID: 30936419
[TBL] [Abstract][Full Text] [Related]
2. miR-99 regulates normal and malignant hematopoietic stem cell self-renewal.
Khalaj M; Woolthuis CM; Hu W; Durham BH; Chu SH; Qamar S; Armstrong SA; Park CY
J Exp Med; 2017 Aug; 214(8):2453-2470. PubMed ID: 28733386
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic potential of GSK-J4, a histone demethylase KDM6B/JMJD3 inhibitor, for acute myeloid leukemia.
Li Y; Zhang M; Sheng M; Zhang P; Chen Z; Xing W; Bai J; Cheng T; Yang FC; Zhou Y
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1065-1077. PubMed ID: 29594337
[TBL] [Abstract][Full Text] [Related]
4. METTL14 Inhibits Hematopoietic Stem/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m
Weng H; Huang H; Wu H; Qin X; Zhao BS; Dong L; Shi H; Skibbe J; Shen C; Hu C; Sheng Y; Wang Y; Wunderlich M; Zhang B; Dore LC; Su R; Deng X; Ferchen K; Li C; Sun M; Lu Z; Jiang X; Marcucci G; Mulloy JC; Yang J; Qian Z; Wei M; He C; Chen J
Cell Stem Cell; 2018 Feb; 22(2):191-205.e9. PubMed ID: 29290617
[TBL] [Abstract][Full Text] [Related]
5. Single-Cell Gene Expression Analyses Reveal Distinct Self-Renewing and Proliferating Subsets in the Leukemia Stem Cell Compartment in Acute Myeloid Leukemia.
Sachs K; Sarver AL; Noble-Orcutt KE; LaRue RS; Antony ML; Chang D; Lee Y; Navis CM; Hillesheim AL; Nykaza IR; Ha NA; Hansen CJ; Karadag FK; Bergerson RJ; Verneris MR; Meredith MM; Schomaker ML; Linden MA; Myers CL; Largaespada DA; Sachs Z
Cancer Res; 2020 Feb; 80(3):458-470. PubMed ID: 31784425
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-223 regulates granulopoiesis but is not required for HSC maintenance in mice.
Trissal MC; DeMoya RA; Schmidt AP; Link DC
PLoS One; 2015; 10(3):e0119304. PubMed ID: 25793640
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of the shortest isoform of histone demethylase LSD1 primes hematopoietic stem cells for malignant transformation.
Wada T; Koyama D; Kikuchi J; Honda H; Furukawa Y
Blood; 2015 Jun; 125(24):3731-46. PubMed ID: 25904247
[TBL] [Abstract][Full Text] [Related]
8. HOTTIP lncRNA Promotes Hematopoietic Stem Cell Self-Renewal Leading to AML-like Disease in Mice.
Luo H; Zhu G; Xu J; Lai Q; Yan B; Guo Y; Fung TK; Zeisig BB; Cui Y; Zha J; Cogle C; Wang F; Xu B; Yang FC; Li W; So CWE; Qiu Y; Xu M; Huang S
Cancer Cell; 2019 Dec; 36(6):645-659.e8. PubMed ID: 31786140
[TBL] [Abstract][Full Text] [Related]
9. IKZF2 Drives Leukemia Stem Cell Self-Renewal and Inhibits Myeloid Differentiation.
Park SM; Cho H; Thornton AM; Barlowe TS; Chou T; Chhangawala S; Fairchild L; Taggart J; Chow A; Schurer A; Gruet A; Witkin MD; Kim JH; Shevach EM; Krivtsov A; Armstrong SA; Leslie C; Kharas MG
Cell Stem Cell; 2019 Jan; 24(1):153-165.e7. PubMed ID: 30472158
[TBL] [Abstract][Full Text] [Related]
10. KDM6B overexpression activates innate immune signaling and impairs hematopoiesis in mice.
Wei Y; Zheng H; Bao N; Jiang S; Bueso-Ramos CE; Khoury J; Class C; Lu Y; Lin K; Yang H; Ganan-Gomez I; Starczynowski DT; Do KA; Colla S; Garcia-Manero G
Blood Adv; 2018 Oct; 2(19):2491-2504. PubMed ID: 30275007
[TBL] [Abstract][Full Text] [Related]
11. KDM6B protects T-ALL cells from NOTCH1-induced oncogenic stress.
Issa N; Bjeije H; Wilson ER; Krishnan A; Dunuwille WMB; Parsons TM; Zhang CR; Han W; Young AL; Ren Z; Ge K; Wang ES; Weng AP; Cashen A; Spencer DH; Challen GA
Leukemia; 2023 Apr; 37(4):728-740. PubMed ID: 36797416
[TBL] [Abstract][Full Text] [Related]
12. The histone lysine demethylase Kdm6b is required for activity-dependent preconditioning of hippocampal neuronal survival.
Wijayatunge R; Chen LF; Cha YM; Zannas AS; Frank CL; West AE
Mol Cell Neurosci; 2014 Jul; 61():187-200. PubMed ID: 24983519
[TBL] [Abstract][Full Text] [Related]
13. Regulation of the JMJD3 (KDM6B) histone demethylase in glioblastoma stem cells by STAT3.
Sherry-Lynes MM; Sengupta S; Kulkarni S; Cochran BH
PLoS One; 2017; 12(4):e0174775. PubMed ID: 28384648
[TBL] [Abstract][Full Text] [Related]
14. Fbxl10 overexpression in murine hematopoietic stem cells induces leukemia involving metabolic activation and upregulation of Nsg2.
Ueda T; Nagamachi A; Takubo K; Yamasaki N; Matsui H; Kanai A; Nakata Y; Ikeda K; Konuma T; Oda H; Wolff L; Honda Z; Wu X; Helin K; Iwama A; Suda T; Inaba T; Honda H
Blood; 2015 May; 125(22):3437-46. PubMed ID: 25872778
[TBL] [Abstract][Full Text] [Related]
15. MLL-AF9- and HOXA9-mediated acute myeloid leukemia stem cell self-renewal requires JMJD1C.
Zhu N; Chen M; Eng R; DeJong J; Sinha AU; Rahnamay NF; Koche R; Al-Shahrour F; Minehart JC; Chen CW; Deshpande AJ; Xu H; Chu SH; Ebert BL; Roeder RG; Armstrong SA
J Clin Invest; 2016 Mar; 126(3):997-1011. PubMed ID: 26878175
[TBL] [Abstract][Full Text] [Related]
16. Mouse acute leukemia develops independent of self-renewal and differentiation potentials in hematopoietic stem and progenitor cells.
Dong F; Bai H; Wang X; Zhang S; Wang Z; Xie M; Zhang S; Wang J; Hao S; Cheng T; Ema H
Blood Adv; 2019 Feb; 3(3):419-431. PubMed ID: 30733302
[TBL] [Abstract][Full Text] [Related]
17. Genetic and epigenetic evolution as a contributor to WT1-mutant leukemogenesis.
Pronier E; Bowman RL; Ahn J; Glass J; Kandoth C; Merlinsky TR; Whitfield JT; Durham BH; Gruet A; Hanasoge Somasundara AV; Rampal R; Melnick A; Koche RP; Taylor BS; Levine RL
Blood; 2018 Sep; 132(12):1265-1278. PubMed ID: 30064973
[TBL] [Abstract][Full Text] [Related]
18. The cell fate determinant Llgl1 influences HSC fitness and prognosis in AML.
Heidel FH; Bullinger L; Arreba-Tutusaus P; Wang Z; Gaebel J; Hirt C; Niederwieser D; Lane SW; Döhner K; Vasioukhin V; Fischer T; Armstrong SA
J Exp Med; 2013 Jan; 210(1):15-22. PubMed ID: 23277453
[TBL] [Abstract][Full Text] [Related]
19. Phf6-null hematopoietic stem cells have enhanced self-renewal capacity and oncogenic potentials.
Hsu YC; Chen TC; Lin CC; Yuan CT; Hsu CL; Hou HA; Kao CJ; Chuang PH; Chen YR; Chou WC; Tien HF
Blood Adv; 2019 Aug; 3(15):2355-2367. PubMed ID: 31395598
[No Abstract] [Full Text] [Related]
20. Targeting lysine demethylase 6B ameliorates ASXL1 truncation-mediated myeloid malignancies in preclinical models.
Ge G; Zhang P; Sui P; Chen S; Yang H; Guo Y; Rubalcava IP; Noor A; Delma CR; Agosto-Peña J; Geng H; Medina EA; Liang Y; Nimer SD; Mesa R; Abdel-Wahab O; Xu M; Yang FC
J Clin Invest; 2024 Jan; 134(1):. PubMed ID: 37917239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
